IL1B and gout: These therapeutic effects are attributed to bioactive compounds, including cucurbitacins, flavonoids, and alkaloids, which inhibit key pro-inflammatory mediators like TNF-α, IL-1β, and IL-6—cytokines involved in the inflammatory response during gout attacks [35,36].